Implementation of the
Medicare Prescription Drug Plan (PDP) and Medicare Advantage (MA)
Plan Disenrollment Reasons Survey (CMS-10316)
Revision of a currently approved collection
No
Regular
07/25/2024
Requested
Previously Approved
36 Months From Approved
12/31/2024
36,050
32,750
6,730
7,055
0
0
This information collection will
survey disenrollees from Medicare Prescription Drug Plans (PDPs)
and Medicare Advantage Prescription Drug Plans (MA-PDs). The
Medicare Prescription Drug, Improvement, and Modernization Act of
2003 (MMA) provides a requirement to collect and report performance
data for Part D prescription drug plans. Specifically, the MMA
under Sec. 1860D-4 (Beneficiary Protections for Qualified
Prescription Drug Coverage) requires CMS to conduct consumer
satisfaction surveys regarding PDPs and MA-PDs - pursuant to
section 1860D-4(d). This data collection complements the
satisfaction data collected through the Medicare CAHPS Survey by
providing dissatisfaction data in the form of reasons for
disenrollment from PDPs and MA-PDs.
CMS proposes to delete eight
items from the MA-PD survey; four items from the MA-only survey,
and six items from the PDP survey to reduce respondent burden. The
collections respondent and hourly burden has decreased from the
last approved version.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.